BiotechTube
Home/Pipeline/CIK Cell Immunotherapy

CIK Cell Immunotherapy

Solid Tumor Oncology

Phase 1Active

Key Facts

Indication
Solid Tumor Oncology
Phase
Phase 1
Status
Active
Company
Cytopeutics

About Cytopeutics

MSC‑based cell therapy platform with halal‑certified products for Asia‑Pacific clinical markets.

View full company profile

Therapeutic Areas

CardiovascularNeurologyMetabolicOphthalmologyOrthopedicsOncologyImmunology

Other Solid Tumor Oncology Drugs

DrugCompanyPhase
Sanoosa‑002SanoosaPreclinical
TJC0434TaiwanJ PharmaceuticalsPreclinical